NCT03793868View on ClinicalTrials.gov

Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral Sclerosis

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

December 4, 2018

Primary Completion Date

August 1, 2020

Study Completion Date

September 1, 2020

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

Perampanel

Oral tablet

OTHER

Placebo

Placebo (not drug)

Trial Locations (1)

32224

Mayo Clinic, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER